As the prevalence and severity of recent RSV infections continue to rise, researchers are prioritizing the rapid development of antivirals and vaccines to help protect our nation’s most vulnerable populations.

With the start of a new year and the closure of one that has passed, we reflect on the shifting healthcare landscape, our sustained organizational growth, and strategies to help our members grow their practices and protect their patients and communities.

About a third of people in the United States will develop shingles, yet only 31.6% of adults are estimated to have received their recommended vaccinations. With adult immunization rates declining in the wake of COVID-19, the risk of contracting or spreading vaccine-preventable diseases is more prominent. Providers play an important role in educating patients on the risks, symptoms, and best prevention methods for shingles.

Recent headlines have reported a new case of polio in the United States, leaving many wondering whether they are at risk. The polio vaccine remains the top recommendation for protecting yourself against the disease. Learn more about polio and immunization recommendations.

With the 2022-2023 flu season rapidly approaching, we dispel some of the most prevalent misconceptions about the influenza virus and vaccine.

As summer comes to a close, children across the country are preparing for the new school year. With schools across the U.S. returning to in-person learning, we discuss the importance of students staying up to date with routine immunizations to reduce the spread of vaccine-preventable illnesses.

Vaccines imitate an infection, triggering an immune system response that helps the body effectively defend itself when it is exposed to the infection in future. While immunity for some diseases can be achieved with a single vaccine dose, factors like disease mutations, immune system health, length of inoculation period, and vaccine type impact the overall protection the vaccine provides and can create a need for two or more vaccine doses to achieve optimal outcomes.

Routine vaccination rates across the country have struggled to return to pre-pandemic levels. However, practices that have leveraged vaccine delivery partnerships, both in the public and private sectors, have seen increased vaccination rates in their communities. Explore these successful partnerships and how your practice can apply similar strategies to increase immunization uptake.

Substantial declines in childhood and adolescent vaccination rates are occurring across the United States, not just at your practice. Learn how to effectively overcome existing barriers to pediatric vaccine hesitancy and protect children from preventable diseases.

Cancer treatment is at the forefront of public health efforts. Providers can reaffirm their commitment to advancing the fight against cancer by educating patients on the role of vaccines in cancer prevention and treatment.

Healthcare and biotech leaders explore opportunities to leverage mRNA technology to protect against harmful illnesses beyond COVID-19.